Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
Year-over-year earnings per share growth rate
3Y CAGR
-3.3%/yr
Quarterly compound
Percentile
P85
Within normal range
vs 3Y Ago
0.9x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.33% |
| Q3 2025 | 37.50% |
| Q2 2025 | 25.00% |
| Q1 2025 | -6.67% |
| Q4 2024 | 1.64% |
| Q3 2024 | 30.68% |
| Q2 2024 | 12.87% |
| Q1 2024 | 22.90% |
| Q4 2023 | -2.34% |
| Q3 2023 | -9.23% |
| Q2 2023 | -33.16% |
| Q1 2023 | -66.04% |
| Q4 2022 | 36.90% |
| Q3 2022 | -255.90% |
| Q2 2022 | 75.92% |
| Q1 2022 | -36.11% |
| Q4 2021 | 5.26% |
| Q3 2021 | -345.16% |
| Q2 2021 | -39.22% |
| Q1 2021 | 191.07% |
| Q4 2020 | -3.70% |
| Q3 2020 | -80.00% |
| Q2 2020 | -66.67% |
| Q1 2020 | -38.46% |
| Q4 2019 | -108.00% |
| Q3 2019 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |